Regeneron Pharmaceuticals Inc (NAS:REGN)
$ 968 12.24 (1.28%) Market Cap: 106.66 Bil Enterprise Value: 98.84 Bil PE Ratio: 28.60 PB Ratio: 3.95 GF Score: 94/100

Regeneron Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 11, 2021 / 01:20PM GMT
Release Date Price: $502.92 (+0.84%)
Cory William Kasimov
JPMorgan Chase & Co, Research Division - Senior Biotechnology Analyst

All right. Good morning, and once again, welcome to the 39th Annual, and first and hopefully only time, Virtual JPMorgan Healthcare Conference.

My name is Cory Kasimov, I'm the senior large-cap biotech analyst, and it's my pleasure to introduce our next company to present, which is Regeneron. Representing Regeneron for the presentation are the company's co-founders: CEO Len Schleifer and CSO George Yancopoulos.

Please note that following this presentation, we will have a Q&A session right here in the same Zoom room. So there's no need to fight the crowd to get to the [Burge] room. (Operator Instructions)

So with that, Len, let me turn things over to you.

Leonard S. Schleifer
Regeneron Pharmaceuticals, Inc. - Co-Founder, President, CEO & Executive Director

Great. Thanks, Cory, and it's really good to be here. Normally, it's these first 15 seconds when I look out at the audience and I get worried that no one's paying attention or

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot